Dr. Iolanda Micco, Associate Director of Chemistry & Alliances, Vipergen
Next-Gen Drug Discovery: An Integrated Micro-Droplet Based Platform
Alexander Alanine, Chief Operating Officer, Bactevo
Accessing genetically tagged heterocycle libraries via a chemoresistant DNA
Andreas Brunschweiger, Research Group Leader, TU, Dortmund
Using antitumor agents to probe the sensitivity contexts of cancer cells and assess the validity of target combinations
Eduard R. Feider, Director, Head of Chemical Core Technologies, Oncology Research, Nerviano Medical Sciences
AI-assisted lead optimization with SynSpace
Greg Makara, ChemPass Ltd.
Inventing, developing and commercialising targeted small-molecule drugs for patients living with cancer
Mark Boys, Principal Research Investigator, Array Biopharma
The Application of Chemical Technologies and Novel Library Design Protocols to Access Desirable Chemical Space for Fragment and DEL-based Lead Discovery
Dr Paul Colbon, CEO and Director, Industrial Chemist
Targeting giants – the pharmacology of adhesions GPCRs
Torsten Schoneberg, Head of the Institute, Rudolf Schönheimer Institute of Biochemistry Medical Faculty, University of Leipzig
More (and better data): How data quality can improve AI predictions
Dr. Yugal Sharma, Senior Director, CAS Solutions
Predicting protein-ligand binding using quantum mechanics
The advantages biosynthesis of cannabinoids has over traditional cultivation and the challenges this presents.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.